BACH_HUMAN - dbPTM
BACH_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID BACH_HUMAN
UniProt AC O00154
Protein Name Cytosolic acyl coenzyme A thioester hydrolase
Gene Name ACOT7
Organism Homo sapiens (Human).
Sequence Length 380
Subcellular Localization Isoform 4: Cytoplasm.
Isoform 6: Cytoplasm.
Isoform 1: Mitochondrion.
Isoform 5: Mitochondrion.
Protein Description Acyl-CoA thioesterases are a group of enzymes that catalyze the hydrolysis of acyl-CoAs to the free fatty acid and coenzyme A (CoASH), providing the potential to regulate intracellular levels of acyl-CoAs, free fatty acids and CoASH. May play an important physiological function in brain. May play a regulatory role by modulating the cellular levels of fatty acyl-CoA ligands for certain transcription factors as well as the substrates for fatty acid metabolizing enzymes, contributing to lipid homeostasis. Has broad specificity, active towards fatty acyl-CoAs with chain-lengths of C8-C18. Has a maximal activity toward palmitoyl-CoA..
Protein Sequence MKLLARALRLCEFGRQASSRRLVAGQGCVGPRRGCCAPVQVVGPRADLPPCGACITGRIMRPDDANVAGNVHGGTILKMIEEAGAIISTRHCNSQNGERCVAALARVERTDFLSPMCIGEVAHVSAEITYTSKHSVEVQVNVMSENILTGAKKLTNKATLWYVPLSLKNVDKVLEVPPVVYSRQEQEEEGRKRYEAQKLERMETKWRNGDIVQPVLNPEPNTVSYSQSSLIHLVGPSDCTLHGFVHGGVTMKLMDEVAGIVAARHCKTNIVTASVDAINFHDKIRKGCVITISGRMTFTSNKSMEIEVLVDADPVVDSSQKRYRAASAFFTYVSLSQEGRSLPVPQLVPETEDEKKRFEEGKGRYLQMKAKRQGHAEPQP
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2 (in isoform 2)Phosphorylation-52.8125159151
2 (in isoform 4)Phosphorylation-52.8125159151
2Ubiquitination------MKLLARALR
------CHHHHHHHH
52.81-
2 (in isoform 3)Phosphorylation-52.8125159151
8 (in isoform 2)Phosphorylation-3.4226270265
8 (in isoform 3)Phosphorylation-3.4226270265
8 (in isoform 4)Phosphorylation-3.4226270265
10 (in isoform 2)Phosphorylation-3.2325693802
10 (in isoform 3)Phosphorylation-3.2325693802
10 (in isoform 4)Phosphorylation-3.2325693802
27AcetylationRRLVAGQGCVGPRRG
CCEECCCCCCCCCCC
13.7319608861
34 (in isoform 7)Phosphorylation-16.4922617229
40 (in isoform 7)Phosphorylation-24.1026270265
42 (in isoform 7)Phosphorylation-4.9625693802
48AcetylationVVGPRADLPPCGACI
EECCCCCCCCCCCEE
5.0719608861
68AcetylationRPDDANVAGNVHGGT
CCCCCCCCCCCCCHH
12.0319608861
78AcetylationVHGGTILKMIEEAGA
CCCHHHHHHHHHHCC
33.7019608861
101UbiquitinationSQNGERCVAALARVE
CCCHHHHHHHHHCCC
4.3522817900
102UbiquitinationQNGERCVAALARVER
CCHHHHHHHHHCCCC
10.6122817900
106UbiquitinationRCVAALARVERTDFL
HHHHHHHCCCCCCCC
31.5121890473
106 (in isoform 6)Ubiquitination-31.5121890473
115 (in isoform 2)Ubiquitination-24.6621890473
115 (in isoform 3)Ubiquitination-24.6621890473
117UbiquitinationTDFLSPMCIGEVAHV
CCCCCCHHHHEEEEE
4.0323000965
117AcetylationTDFLSPMCIGEVAHV
CCCCCCHHHHEEEEE
4.0319608861
117 (in isoform 6)Ubiquitination-4.0321890473
121UbiquitinationSPMCIGEVAHVSAEI
CCHHHHEEEEEEEEE
3.6323000965
122UbiquitinationPMCIGEVAHVSAEIT
CHHHHEEEEEEEEEE
7.9622817900
123UbiquitinationMCIGEVAHVSAEITY
HHHHEEEEEEEEEEE
21.1722817900
126 (in isoform 2)Ubiquitination-15.8921890473
126 (in isoform 3)Ubiquitination-15.8921890473
127UbiquitinationEVAHVSAEITYTSKH
EEEEEEEEEEEECCC
28.4921890473
127 (in isoform 5)Ubiquitination-28.4921890473
138UbiquitinationTSKHSVEVQVNVMSE
ECCCEEEEEEEECCC
7.8423000965
138AcetylationTSKHSVEVQVNVMSE
ECCCEEEEEEEECCC
7.8419608861
138 (in isoform 5)Ubiquitination-7.8421890473
142UbiquitinationSVEVQVNVMSENILT
EEEEEEEECCCCCCC
4.7323000965
143UbiquitinationVEVQVNVMSENILTG
EEEEEEECCCCCCCC
3.3322817900
147UbiquitinationVNVMSENILTGAKKL
EEECCCCCCCCCHHH
2.9822817900
147UbiquitinationVNVMSENILTGAKKL
EEECCCCCCCCCHHH
2.9821890473
147 (in isoform 4)Ubiquitination-2.9821890473
152UbiquitinationENILTGAKKLTNKAT
CCCCCCCHHHCCCCE
50.0522817900
153UbiquitinationNILTGAKKLTNKATL
CCCCCCHHHCCCCEE
61.0722817900
153AcetylationNILTGAKKLTNKATL
CCCCCCHHHCCCCEE
61.0725953088
154UbiquitinationILTGAKKLTNKATLW
CCCCCHHHCCCCEEE
6.6832015554
157AcetylationGAKKLTNKATLWYVP
CCHHHCCCCEEEEEE
37.2023954790
157UbiquitinationGAKKLTNKATLWYVP
CCHHHCCCCEEEEEE
37.2021890473
157 (in isoform 1)Ubiquitination-37.2021890473
158UbiquitinationAKKLTNKATLWYVPL
CHHHCCCCEEEEEEC
15.2523000965
158UbiquitinationAKKLTNKATLWYVPL
CHHHCCCCEEEEEEC
15.2521890473
158AcetylationAKKLTNKATLWYVPL
CHHHCCCCEEEEEEC
15.2519608861
158 (in isoform 4)Ubiquitination-15.2521890473
159PhosphorylationKKLTNKATLWYVPLS
HHHCCCCEEEEEECC
21.3168724543
162PhosphorylationTNKATLWYVPLSLKN
CCCCEEEEEECCCCC
8.7068710517
162UbiquitinationTNKATLWYVPLSLKN
CCCCEEEEEECCCCC
8.7023000965
166PhosphorylationTLWYVPLSLKNVDKV
EEEEEECCCCCCCCE
31.0920068231
168AcetylationWYVPLSLKNVDKVLE
EEEECCCCCCCCEEE
52.1019608861
168UbiquitinationWYVPLSLKNVDKVLE
EEEECCCCCCCCEEE
52.1023000965
168 (in isoform 1)Ubiquitination-52.1021890473
172AcetylationLSLKNVDKVLEVPPV
CCCCCCCCEEECCCE
44.4223954790
172UbiquitinationLSLKNVDKVLEVPPV
CCCCCCCCEEECCCE
44.4223000965
172MalonylationLSLKNVDKVLEVPPV
CCCCCCCCEEECCCE
44.4226320211
175UbiquitinationKNVDKVLEVPPVVYS
CCCCCEEECCCEEEC
56.8432015554
181PhosphorylationLEVPPVVYSRQEQEE
EECCCEEECHHHHHH
9.81142163
182PhosphorylationEVPPVVYSRQEQEEE
ECCCEEECHHHHHHH
18.8425394399
188UbiquitinationYSRQEQEEEGRKRYE
ECHHHHHHHHHHHHH
66.5032015554
188AcetylationYSRQEQEEEGRKRYE
ECHHHHHHHHHHHHH
66.5019608861
194PhosphorylationEEEGRKRYEAQKLER
HHHHHHHHHHHHHHH
20.7428152594
195UbiquitinationEEGRKRYEAQKLERM
HHHHHHHHHHHHHHH
48.9732015554
198AcetylationRKRYEAQKLERMETK
HHHHHHHHHHHHHHH
60.4019608861
198UbiquitinationRKRYEAQKLERMETK
HHHHHHHHHHHHHHH
60.4019608861
205UbiquitinationKLERMETKWRNGDIV
HHHHHHHHCCCCCCC
30.7432015554
232UbiquitinationYSQSSLIHLVGPSDC
EECCCCEEEECCCCC
21.5421890473
232AcetylationYSQSSLIHLVGPSDC
EECCCCEEEECCCCC
21.5419608861
232 (in isoform 6)Ubiquitination-21.5421890473
235UbiquitinationSSLIHLVGPSDCTLH
CCCEEEECCCCCEEE
23.5022817900
253UbiquitinationHGGVTMKLMDEVAGI
CCCCHHHHHHHHHHH
3.4821890473
253AcetylationHGGVTMKLMDEVAGI
CCCCHHHHHHHHHHH
3.4819608861
253 (in isoform 5)Ubiquitination-3.4821890473
254SulfoxidationGGVTMKLMDEVAGIV
CCCHHHHHHHHHHHH
3.2621406390
256UbiquitinationVTMKLMDEVAGIVAA
CHHHHHHHHHHHHHH
21.9422817900
267UbiquitinationIVAARHCKTNIVTAS
HHHHHCCCCCEEEEE
38.18-
268PhosphorylationVAARHCKTNIVTASV
HHHHCCCCCEEEEEC
35.2620068231
270UbiquitinationARHCKTNIVTASVDA
HHCCCCCEEEEECCE
3.3522053931
272PhosphorylationHCKTNIVTASVDAIN
CCCCCEEEEECCEEE
14.9320068231
273UbiquitinationCKTNIVTASVDAINF
CCCCEEEEECCEEEC
9.1721890473
273UbiquitinationCKTNIVTASVDAINF
CCCCEEEEECCEEEC
9.1721890473
273AcetylationCKTNIVTASVDAINF
CCCCEEEEECCEEEC
9.1719608861
273 (in isoform 4)Ubiquitination-9.1721890473
274PhosphorylationKTNIVTASVDAINFH
CCCEEEEECCEEECC
15.9120068231
276UbiquitinationNIVTASVDAINFHDK
CEEEEECCEEECCHH
38.9522817900
283AcetylationDAINFHDKIRKGCVI
CEEECCHHHCCCCEE
35.5219608861
283UbiquitinationDAINFHDKIRKGCVI
CEEECCHHHCCCCEE
35.5222817900
2832-HydroxyisobutyrylationDAINFHDKIRKGCVI
CEEECCHHHCCCCEE
35.52-
283 (in isoform 1)Ubiquitination-35.5221890473
286UbiquitinationNFHDKIRKGCVITIS
ECCHHHCCCCEEEEC
61.2022817900
286MalonylationNFHDKIRKGCVITIS
ECCHHHCCCCEEEEC
61.2026320211
286AcetylationNFHDKIRKGCVITIS
ECCHHHCCCCEEEEC
61.2026051181
291UbiquitinationIRKGCVITISGRMTF
HCCCCEEEECCEEEE
6.6822053931
300PhosphorylationSGRMTFTSNKSMEIE
CCEEEECCCCCEEEE
37.7630624053
303PhosphorylationMTFTSNKSMEIEVLV
EEECCCCCEEEEEEE
26.3730624053
304SulfoxidationTFTSNKSMEIEVLVD
EECCCCCEEEEEEEE
6.8530846556
304UbiquitinationTFTSNKSMEIEVLVD
EECCCCCEEEEEEEE
6.8524816145
305UbiquitinationFTSNKSMEIEVLVDA
ECCCCCEEEEEEEEC
42.9924816145
311UbiquitinationMEIEVLVDADPVVDS
EEEEEEEECCCCCCC
40.8822053931
318UbiquitinationDADPVVDSSQKRYRA
ECCCCCCCHHHHHHH
24.0633845483
319PhosphorylationADPVVDSSQKRYRAA
CCCCCCCHHHHHHHH
34.9524719451
321AcetylationPVVDSSQKRYRAASA
CCCCCHHHHHHHHHH
54.037350191
321UbiquitinationPVVDSSQKRYRAASA
CCCCCHHHHHHHHHH
54.0322053931
321 (in isoform 1)Ubiquitination-54.0321890473
325UbiquitinationSSQKRYRAASAFFTY
CHHHHHHHHHHHHEE
9.2424816145
326UbiquitinationSQKRYRAASAFFTYV
HHHHHHHHHHHHEEE
7.7524816145
327PhosphorylationQKRYRAASAFFTYVS
HHHHHHHHHHHEEEE
25.32102778137
336PhosphorylationFFTYVSLSQEGRSLP
HHEEEEECCCCCCCC
20.7630624053
339UbiquitinationYVSLSQEGRSLPVPQ
EEEECCCCCCCCCCC
19.4833845483
345UbiquitinationEGRSLPVPQLVPETE
CCCCCCCCCCCCCCH
21.6124816145
346UbiquitinationGRSLPVPQLVPETED
CCCCCCCCCCCCCHH
56.1624816145
351PhosphorylationVPQLVPETEDEKKRF
CCCCCCCCHHHHHHH
42.54110734971
355UbiquitinationVPETEDEKKRFEEGK
CCCCHHHHHHHHCCC
62.6624816145
3552-HydroxyisobutyrylationVPETEDEKKRFEEGK
CCCCHHHHHHHHCCC
62.66-
355AcetylationVPETEDEKKRFEEGK
CCCCHHHHHHHHCCC
62.6625953088
356UbiquitinationPETEDEKKRFEEGKG
CCCHHHHHHHHCCCC
61.3424816145
359UbiquitinationEDEKKRFEEGKGRYL
HHHHHHHHCCCCHHH
70.6333845483
365PhosphorylationFEEGKGRYLQMKAKR
HHCCCCHHHHHHHHH
15.2328102081
369UbiquitinationKGRYLQMKAKRQGHA
CCHHHHHHHHHCCCC
37.4833845483
369AcetylationKGRYLQMKAKRQGHA
CCHHHHHHHHHCCCC
37.4825953088

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of BACH_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of BACH_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of BACH_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
AL9A1_HUMANALDH9A1physical
22863883
G3P_HUMANGAPDHphysical
22863883
PDIA3_HUMANPDIA3physical
22863883
RCC2_HUMANRCC2physical
22863883
DHSO_HUMANSORDphysical
22863883
UBQL1_HUMANUBQLN1physical
25416956
THAP1_HUMANTHAP1physical
25416956
PCBP1_HUMANPCBP1physical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of BACH_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-78; LYS-168; LYS-198 ANDLYS-283, AND MASS SPECTROMETRY.

TOP